“Performance and Clinical Decision-Making Using the Prognostic 40-Gene Expression Profile (40-GEP) Test in 1,018 Patients With High-Risk Cutaneous Squamous Cell Carcinoma (SCC)”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 6, Nov. 2022, p. s96, https://doi.org/10.25251/skin.6.supp.96.